1. Nuottamo, Marjo Eveliina, Häppölä, Paavo, Artto, Ville, Kaunisto, Mari Anneli, Wessman, Maija. 2022. NCOR2 is a novel candidate gene for migraine-epilepsy phenotype. In Cephalalgia : an international journal of headache, 42, 631-644. doi:10.1177/03331024211068065. https://pubmed.ncbi.nlm.nih.gov/35166138/
2. Tsai, Kelvin K, Huang, Shenq-Shyang, Northey, Jason J, Lakins, Jonathon N, Weaver, Valerie M. 2022. Screening of organoids derived from patients with breast cancer implicates the repressor NCOR2 in cytotoxic stress response and antitumor immunity. In Nature cancer, 3, 734-752. doi:10.1038/s43018-022-00375-0. https://pubmed.ncbi.nlm.nih.gov/35618935/
3. Prasun, Pankaj. 2024. NCOR2 Is a Candidate Gene for Neurodevelopmental Disorders. In Pediatric neurology, 156, 1-3. doi:10.1016/j.pediatrneurol.2024.04.003. https://pubmed.ncbi.nlm.nih.gov/38677047/
4. Sharma, Nikhil, Pollina, Elizabeth A, Nagy, M Aurel, Lin, Cindy, Greenberg, Michael E. 2019. ARNT2 Tunes Activity-Dependent Gene Expression through NCoR2-Mediated Repression and NPAS4-Mediated Activation. In Neuron, 102, 390-406.e9. doi:10.1016/j.neuron.2019.02.007. https://pubmed.ncbi.nlm.nih.gov/30846309/
5. Zou, Gengyi, Zhang, Xiaotong, Wang, Lun, Xiang, Rong, Shi, Yi. 2020. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. In Theranostics, 10, 6839-6853. doi:10.7150/thno.43622. https://pubmed.ncbi.nlm.nih.gov/32550907/
6. Paluvai, Harikrishnareddy, Shanmukha, Kumar D, Tyedmers, Jens, Backs, Johannes. 2023. Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseases. In Frontiers in molecular biosciences, 10, 1190094. doi:10.3389/fmolb.2023.1190094. https://pubmed.ncbi.nlm.nih.gov/37674539/
7. Clark, Iain C, Wheeler, Michael A, Lee, Hong-Gyun, Quintana, Francisco J, Abate, Adam R. 2023. Identification of astrocyte regulators by nucleic acid cytometry. In Nature, 614, 326-333. doi:10.1038/s41586-022-05613-0. https://pubmed.ncbi.nlm.nih.gov/36599367/
8. Long, Mark D, Jacobi, Justine J, Singh, Prashant K, Campbell, Moray J, Smiraglia, Dominic J. . Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer. In Cell reports, 37, 110109. doi:10.1016/j.celrep.2021.110109. https://pubmed.ncbi.nlm.nih.gov/34910907/